1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Amyloidosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balestrieri, ML; Irace, G; Sirangelo, I | 1 |
| Arnoux, B; Canaud, B; Chavis, C; Cristol, JP; Damon, M; Mion, C | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Amyloidosis
| Article | Year |
|---|---|
Amyloid toxicity and platelet-activating factor signaling.
Topics: Amyloid; Amyloidosis; Animals; Humans; Inflammation Mediators; Neurons; Neuroprotective Agents; Oxidative Stress; Platelet Activating Factor; Protein Multimerization; Signal Transduction | 2013 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Amyloidosis
| Article | Year |
|---|---|
Platelet-activating factor production during hemodialysis: effect of BN 52021.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Amyloidosis; beta 2-Microglobulin; Biocompatible Materials; Blood Platelets; Calcimycin; Cellulose; Diterpenes; Double-Blind Method; Female; Ginkgolides; Humans; Hydroxyeicosatetraenoic Acids; Lactones; Leukopenia; Lipoxygenase; Lymphocyte Activation; Male; Membranes, Artificial; Middle Aged; Platelet Activating Factor; Platelet Activation; Random Allocation; Renal Dialysis | 1992 |